APA (7th ed.) Citation

JD, R., NP, M., RM, H., ER, L., CA, J., CF, K., . . . PJ, M. (2019). Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy. The Journal of clinical investigation, 129(8), 3171. https://doi.org/10.1172/JCI125538

Chicago Style (17th ed.) Citation

JD, Roberts, et al. "Ankyrin-B Dysfunction Predisposes to Arrhythmogenic Cardiomyopathy and Is Amenable to Therapy." The Journal of Clinical Investigation 129, no. 8 (2019): 3171. https://doi.org/10.1172/JCI125538.

MLA (9th ed.) Citation

JD, Roberts, et al. "Ankyrin-B Dysfunction Predisposes to Arrhythmogenic Cardiomyopathy and Is Amenable to Therapy." The Journal of Clinical Investigation, vol. 129, no. 8, 2019, p. 3171, https://doi.org/10.1172/JCI125538.